Thyas

Developer of induced pluripotent stem cells technology to treat cancer

placeKyoto, Kyoto, Japan calendar_todayFounded 2015 groups4 employees language thyas.co.jp

4 investors on record.

Investor type	Count	Share
Venture capital	4	100%

Coming soon